Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115324) titled 'Analysis of the efficacy of targeted therapy or immunotherapy in patients with lung cancer complicated with diabetes: A multicenter retrospective study' on Dec. 24, 2025.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The Army Characteristic Medical Center of the People's Liberation Army of China
Condition:
Lung cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-24
Target Sample Size: Observation group:100;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=301508
Published by HT Digital ...